GINA: Intended Effect Unintended Consequences - PowerPoint PPT Presentation

About This Presentation
Title:

GINA: Intended Effect Unintended Consequences

Description:

Timing, GINA is Law and the Future of Genomic Medicine, The Gene Sherpa Blogspot, ... After Long Wait, GINA Becomes Law, Clinical Laboratory News, Volume 34, ... – PowerPoint PPT presentation

Number of Views:91
Avg rating:3.0/5.0
Slides: 28
Provided by: ehc6
Category:

less

Transcript and Presenter's Notes

Title: GINA: Intended Effect Unintended Consequences


1
  • GINA Intended EffectUnintended Consequences
  • Tam Woodrum, JD
  • Pfizer

2
Agenda
  • Genetic Information Nondiscrimination Act (GINA)?
  • Intended Effect
  • Regulatory Changes to Come
  • The European Experience
  • Lessons Learned

3
Intended Effect - A New Era of Civil Rights...
  • WATCH MOVIE CLIP -
  • GINA LEGILSATION

4
Intended Effect
  • Two Actors
  • Health Insurers
  • Employers
  • Genetic Information Derived From a Genetic Test
  • "Genetic information" is defined as
  • an individuals own genetic tests
  • the genetic tests of family members and
  • the manifestation of a disease or disorder in
    family members.
  • Genetic test is defined as assessment of
  • Genotypes
  • Mutations
  • Chromosomal changes

5
Is the Fear of Discrimination Real?
6
Problem Statement
  • The privacy and protection of genetic
    information is essential to the progress of
    medicine, as well as improving the quality of
    care for every person.
  • Personalized Medicine Coalition
  • At the National Institutes for Health, fear of
    genetic discrimination is the most commonly cited
    reason that people decline to participate in
    research on potentially life-saving genetic
    testing for colon cancer and breast cancer.
    One-third of eligible participants have declined
    on this basis.
  • Francis S. Collins, MD Phd, Director of the
    National Human Genome Research Institute

7
Current Laws Are Not Enough?
  • HIPAA
  • Does not prevent insurers or employers from
  • requiring genetic information or
  • denying coverage/employment based on it
  • State Laws
  • Inconsistent

8
Current Laws Are Not Enough?
  • Watch Movie Clip
  • State of MN Newborn Screening Data

9
Laws Amended by GINA
  • ERISA, PHSA and Internal Revenue Code
  • Prevent genetic discrimination in provision of
    health insurance
  • HIPAA
  • Includes genetic information in the definition of
    protected health information
  • Prohibits insurers from disclosing an
    individuals genetic information for underwriting
    purposes

10
Anticipated Regulations - Federal Agencies
  • Department of Health and Human Services
  • Department of Labor
  • Equal Employment Opportunity Commission

11
Potential Trouble Spots
  • What Motivated That Group Premium Adjustment?
  • Specific Genetic Test Results - VIOLATION
  • General Genetic Tests Identify Group at
    Increased Risk - OK
  • Does not apply to the following types of
    insurance
  • Life
  • Long term care
  • Supplemental medicare
  • Veterans Administration health benefits
  • Excludes manifested disease that may have a
    genetic basis

12
European Experience
  • Since 1990 most European countries enacted
    genetic nondiscrimination legislation for life
    and health insurance
  • Effective?
  • Laws generally ineffective in preventing use of
    genetic information in insurance practices
  • Lack of clear definition of genetic test or
    genetic information
  • Laws have not been able to keep up with progress
    in genomics knowledge
  • Difficult to maintain distinction between genetic
    and non-genetic information
  • Laws have not prevented public fear of genetic
    discrimination

13
European Experience

The Eurobarometer, Europeans and Biotechnology
in 2005 Patterns and Trends
14
European Experience
  • Unintended Effect
  • Other types of of acceptable underwriting
    practices have risen
  • Focus on Lifestyle Risks
  • Smoking
  • Nutrition/Obesity
  • Noncompliance with prescribed therapy
  • Differentiate risk taker from risk carrier

15
European Experience
  • Suggested Remediation Approach
  • Clarify definition of what distinguishes genetic
    information from other medical information
  • A number of experts believe this will become
    increasingly difficult as the science advances
  • Completely overhaul underwriting practices

16
European Experience
  • A publicly funded survey found that people cannot
    agree on what exactly genetic testing is or does,
    or what kind of information it covers, even among
    the specialists
  • Oviedo Convention Article 12
  • Declares that tests that are predictive of
    genetic diseases, or which serve to identify the
    subject as a carrier of a gene responsible for a
    disease, or to detect a genetic predisposition or
    susceptibility to a disease, may be performed
    only for health purposes or for scientific
    research linked to health purposes, and subject
    to appropriate genetic counseling
  • Ratified by 21 European countries

17
Genetic Exceptionalism
  • Arguments for Treating Genetic Information as a
    Special Class
  • Goes to the core of our uniqueness
  • Potential impact on individual as well as
    relatives
  • Can be extrapolated to entire groups
  • Predictive value can range from certain to
    minimal likelihood of occurence
  • Entire record contained in a small sample in
    archival format

18
Genetic Exceptionalism
  • Argument Against
  • Sensitivity is a relative concept regardless of
    the type of information
  • Low predictive genetic mutation versus
  • History of substance abuse
  • Other types of information can be just as
    predictive of future disease
  • Early asymptomatic phase of infection
  • Lipid levels

19
Current Legal Approaches to Genetic Privacy
  • Personal Information
  • Encompasses genetic information within the
    broader definition of personal data
  • Focuses on those socially acceptable purposes for
    which personal information may be collected, used
    and disclosed, how that ought to be done, and
    under what conditions
  • Centers primarily on individual consent and does
    not consider important familial and communal
    interests in information

France
Canada
New Zealand
20
Current Legal Approaches to Genetic Privacy
  • Sensitive Information
  • Deems certain types of information to be
    sensitive based on the source of the information
    and the degree of intimacy related to it
  • Prohibits the processing for sensitive data
    unless it is required by law, it is for public
    health purposes, or if explicit consent is
    obtained
  • Does not consider important familial and communal
    interests in information

European Parliament
Iceland
21
Current Legal Approaches to Genetic Privacy
  • Health (Medical) Information
  • Genetic information is covered either expressly
    or impliedly by the definitions of health or
    medical information
  • Limited in its scope of application - only covers
    information kept by specific entities (i.e.
    medical facilities, government funded entities,
    public institutions, health data custodians or
    trustees, etc)?
  • May consider important familial and communal
    interests in information

Australia
US Pre-GINA
22
Current Legal Approaches to Genetic Privacy
  • Genetic Information
  • Creates unique set of rules specific to genetic
    information
  • Forced to define genetic information and to
    distinguish it from other types of data (i.e.,
    general personal information and health
    information)?
  • Focuses on the type of information, rather than
    those socially acceptable purposes for which
    personal information may be collected, used and
    disclosed, how that ought to be done and under
    what conditions
  • Considers important familial and communal
    interests in information

Israel
US Post-GINA
United Nations
23
What Approach Will Prevail?
24
What Approach Will Prevail?
25
  • Bibliography
  • Hudson, K., Holohan, M. K., Collins, F. S.
    Keeping Pace with the Times - The Genetic
    Information Nondiscrimination Act of 2008, Volume
    3582261-2663, Number 25, June 19, 2008.
  • http//content.nejm.org/cgi/content/full/358/25/26
    61
  • Bettinger, Blaine. GINA A Primer. The Genetic
    Genealogist web site.
  • http//www.thegeneticgenealogist.com/2007/04/27/gi
    na-a-primer/
  • Coalition for Genetic Fairness web site.
  • http//www.geneticfairness.org/act.html
  • State Genetics Employment Laws, National
    Conference of State Legislatures web site.
  • http//www.ncsl.org/programs/health/genetics/ndisc
    rim.htm
  • Murphy, Steve. Timing, GINA is Law and the
    Future of Genomic Medicine, The Gene Sherpa
    Blogspot, May 21, 2008.
  • http//thegenesherpa.blogspot.com/2008/05/timing-g
    ina-is-law-and-future-of.html
  • National Geneome Institute web site.
  • http//www.genome.gov/10002328

26
  • Bibliography
  • Kibak, Phil. After Long Wait, GINA Becomes Law,
    Clinical Laboratory News, Volume 34, Number 7,
    July 2008.
  • http//www.aacc.org/publications/cln/2008/July/Pag
    es/cover2_0708.aspx
  • Ford Harrison, LLP. Legal Alert Employers
    and Insurers Meet GINA - The Newest Addition to
    the Federal Discrimination Law Family, Ford
    Harrison website, May 23, 2008.
  • http//www.fordharrison.com/shownews.aspx?Show373
    5
  • Akerman Senterfitt LLP. GINA Establishes
    Protection for Claims of Genetic Bias, Akerman
    Senterfitt web site, May 27, 2008.
  • http//www.akerman.com/documents/LE_AkerAlert_0508
    .pdf
  • Aaron Hamvas, MD Katherine K. Madden, RN
    Lawrence M. Nogee, MD Michelle A. Trusgnich, BS
  • Daniel J. Wegner, BS Hillary B. Heins, BS F.
    Sessions Cole, MD. Informed Consent for Genetic
    Research, ARCH PEDIATR ADOLESC MED/ VOL 158,
    JUNE 2004.
  • http//archpedi.ama-assn.org/cgi/reprint/158/6/551
    .pdf
  • Terry, S., Boughman, J. PhD. GINA Provides
    Bioindustry Boost, Genetic Enginerring
    Biotechnology News, Vol. 28, No. 13, July 1,
    2008.
  • http//www.genengnews.com/articles/chitem.aspx?aid
    2522
  • Winter, Peter Ed. Genetic Test Industry Faces
    Tough Challenges With Consumers, Survey Finds,
    Burrill Company website, June 17, 2008.

27
  • Bibliography
  • Grushcow, J. Passage of Genetic Information
    Nondiscrimination Act (GINA) in the U.S. Opens
    the Door for Personalized Medicine, Ogilvy
    Renault LLP web site, May 28, 2008.
  • http//www.ogilvyrenault.com/fr/centreDeResources_
    1917.htm
  • Van Hoyweghen, I. PhD., Hortsman, K., PhD.
    European Practices of Genetic Information and
    Insurance - Lessons for the Genetic Information
    Nondiscrimination Act, Journal of the American
    Medical Association, 2008 300(3) 326-327, July
    16, 2008.
  • http//jama.ama-assn.org/cgi/content/full/300/3/32
    6
  • EuroGentest (EU-funded Network of Excellence
    (NoE) - Unit 3 Public Health(. Definitions of
    Genetic Testing, 3rd Draft, April 2008.
  • http//www.eurogentest.org/unit3/
  • Sequeiros, J. MD, PhD. Do You Know What Genetic
    Testing Stands For? Jorge Sequeiros Blog site,
    April 6, 2008.
  • http//www.jorgesequeiros.com/2008/04/do-you-know-
    what-genetic-testing-stands.html
  • Human Genome Project Information web site.
  • http//www.ornl.gov/sci/techresources/Human_Genome
    /elsi/legislat.shtml
  • Kosseim, P., Letendre, M., Knoppers, B. M.
    Protecting Genetic Information A Comparison of
    Normative Approaches, GenEdit, 2004.
  • https//papyrus.bib.umontreal.ca/dspace/handle/186
    6/2277?languageen
Write a Comment
User Comments (0)
About PowerShow.com